Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market Insights, Forecast to 2027
Summary:
β-Lactams are the most widely used class of antibiotics. Since the discovery of benzylpenicillin in the 1920s, thousands of new penicillin derivatives and related β-lactam classes of cephalosporins, cephamycins, monobactams, and carbapenems have been discovered. Each new class of b-lactam has been developed either to increase the spectrum of activity to include additional bacterial species or to address specific resistance mechanisms that have arisen in the targeted bacterial population. Resistance to β-lactams is primarily because of bacterially produced β-lactamase enzymes that hydrolyze the β-lactam ring, thereby inactivating the drug. The newest effort to circumvent resistance is the development of novel broad-spectrum β-lactamase inhibitors that work against many problematic β-lactamases, including cephalosporinases and serine-based carbapenemases, which severely limit therapeutic options.
In the global market, the core manufacturers of Beta-lactam and Beta-lactamase Inhibitors include Pfizer and Novartis (Sandoz) etc, and the top 2 manufacturers account for about 10% of the market share. The market include Asia Pacific, Europe and North America, with a share of 33%, 32% and 28%. cephalosporins accounted for 28% and penicillins accounted for 17%. The product is mainly used in intravenous and oral, with a share of 65% and 35%.
Market Analysis and Insights: Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market
This report focuses on global and Japan Beta-lactam and Beta-lactamase Inhibitors market.
In 2020, the global Beta-lactam and Beta-lactamase Inhibitors market size was US$ 23720 million and it is expected to reach US$ 31780 million by the end of 2027, with a CAGR of 1.9% during 2021-2027. In Japan the Beta-lactam and Beta-lactamase Inhibitors market size is expected to grow from US$ million in 2020 to US$ million by 2027, at a CAGR of % during the forecast period.
Global Beta-lactam and Beta-lactamase Inhibitors Scope and Market Size
Beta-lactam and Beta-lactamase Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Beta-lactam and Beta-lactamase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Beta-lactam and Beta-lactamase Inhibitors market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.
Segment by Type
Penicillins
Cephalosporins
Carbapenems
Monobactams
Combinations
Segment by Application
Oral
Intravenous
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
Novartis (Sandoz)
TEVA
Merck
AbbVie (Allergan)
Sumitomo Dainippon
Hikma
Aurobindo Pharma
Wockhardt
Lupin Limited
Fresenius Kabi
B. Braun
USantibiotics
Qilu Pharmaceutical
ACS Dobfar
Nichi-Iko (Sagent)
Antibiotice
Global and Japan Beta lactam and Beta lactamase Inhibitors market
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets